210 related articles for article (PubMed ID: 35192404)
1. A Novel Artificial Intelligence-Powered Method for Prediction of Early Recurrence of Prostate Cancer After Prostatectomy and Cancer Drivers.
Huang W; Randhawa R; Jain P; Hubbard S; Eickhoff J; Kummar S; Wilding G; Basu H; Roy R
JCO Clin Cancer Inform; 2022 Feb; 6():e2100131. PubMed ID: 35192404
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of an Artificial Intelligence-Powered Platform for Prostate Cancer Grading and Quantification.
Huang W; Randhawa R; Jain P; Iczkowski KA; Hu R; Hubbard S; Eickhoff J; Basu H; Roy R
JAMA Netw Open; 2021 Nov; 4(11):e2132554. PubMed ID: 34730818
[TBL] [Abstract][Full Text] [Related]
3. Nuclear Shape and Architecture in Benign Fields Predict Biochemical Recurrence in Prostate Cancer Patients Following Radical Prostatectomy: Preliminary Findings.
Lee G; Veltri RW; Zhu G; Ali S; Epstein JI; Madabhushi A
Eur Urol Focus; 2017 Oct; 3(4-5):457-466. PubMed ID: 28753763
[TBL] [Abstract][Full Text] [Related]
4. A systematic review and meta-analysis of artificial intelligence diagnostic accuracy in prostate cancer histology identification and grading.
Morozov A; Taratkin M; Bazarkin A; Rivas JG; Puliatti S; Checcucci E; Belenchon IR; Kowalewski KF; Shpikina A; Singla N; Teoh JYC; Kozlov V; Rodler S; Piazza P; Fajkovic H; Yakimov M; Abreu AL; Cacciamani GE; Enikeev D;
Prostate Cancer Prostatic Dis; 2023 Dec; 26(4):681-692. PubMed ID: 37185992
[TBL] [Abstract][Full Text] [Related]
5. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.
Brockman JA; Alanee S; Vickers AJ; Scardino PT; Wood DP; Kibel AS; Lin DW; Bianco FJ; Rabah DM; Klein EA; Ciezki JP; Gao T; Kattan MW; Stephenson AJ
Eur Urol; 2015 Jun; 67(6):1160-1167. PubMed ID: 25301759
[TBL] [Abstract][Full Text] [Related]
6. Dr. Answer AI for Prostate Cancer: Predicting Biochemical Recurrence Following Radical Prostatectomy.
Park J; Rho MJ; Moon HW; Kim J; Lee C; Kim D; Kim CS; Jeon SS; Kang M; Lee JY
Technol Cancer Res Treat; 2021; 20():15330338211024660. PubMed ID: 34180308
[TBL] [Abstract][Full Text] [Related]
7. Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer.
Palisaar RJ; Graefen M; Karakiewicz PI; Hammerer PG; Huland E; Haese A; Fernandez S; Erbersdobler A; Henke RP; Huland H
Eur Urol; 2002 Feb; 41(2):155-61. PubMed ID: 12074402
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of 2005 Gleason grade modification. Population-based study of biochemical recurrence following radical prostatectomy.
Thomsen FB; Folkvaljon Y; Brasso K; Loeb S; Robinson D; Egevad L; Stattin P
J Surg Oncol; 2016 Nov; 114(6):664-670. PubMed ID: 27511833
[TBL] [Abstract][Full Text] [Related]
9. Non-organ confined stage and upgrading rates in exclusive PSA high-risk prostate cancer patients.
Hoeh B; Flammia RS; Hohenhorst L; Sorce G; Chierigo F; Tian Z; Saad F; Gallucci M; Briganti A; Terrone C; Shariat SF; Graefen M; Tilki D; Kluth LA; Mandel P; Becker A; Chun FKH; Karakiewicz PI
Prostate; 2022 May; 82(6):687-694. PubMed ID: 35188982
[TBL] [Abstract][Full Text] [Related]
10. Weighted Gleason Grade Group (WGGG): A new prostate cancer biopsy reporting system with prognostic potential.
Waingankar N; Martini A; Griffiths L; Shah P; Paulucci DJ; Kotamarti S; Gul Z; Elmasri M; Yaskiv O; Haines K; Lerner S; Vira M; Kavoussi LR; Tewari AK; Kapoor DA; Olsson CA
Urol Oncol; 2020 Mar; 38(3):78.e15-78.e21. PubMed ID: 31796374
[TBL] [Abstract][Full Text] [Related]
11. Incorporating artificial intelligence in urology: Supervised machine learning algorithms demonstrate comparative advantage over nomograms in predicting biochemical recurrence after prostatectomy.
Tan YG; Fang AHS; Lim JKS; Khalid F; Chen K; Ho HSS; Yuen JSP; Huang HH; Tay KJ
Prostate; 2022 Feb; 82(3):298-305. PubMed ID: 34855228
[TBL] [Abstract][Full Text] [Related]
12. Genetic predisposition to early recurrence in clinically localized prostate cancer.
Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
[TBL] [Abstract][Full Text] [Related]
14. Prostate Cancer Risk Prediction and Online Calculation Based on Machine Learning Algorithm.
Wang C; Chang QX; Wang XM; Wang KY; Wang H; Cui Z; Li CP
Chin Med Sci J; 2022 Sep; 37(3):210-217. PubMed ID: 36321176
[TBL] [Abstract][Full Text] [Related]
15. Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomy.
Khan MA; Walsh PC; Miller MC; Bales WD; Epstein JI; Mangold LA; Partin AW; Veltri RW
Cancer; 2003 Dec; 98(12):2583-91. PubMed ID: 14669277
[TBL] [Abstract][Full Text] [Related]
16. The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy.
Abdollah F; Scattoni V; Raber M; Roscigno M; Briganti A; Suardi N; Gallina A; Capitanio U; Freschi M; Salonia A; Cestari A; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2011 Aug; 108(3):366-71. PubMed ID: 21087451
[TBL] [Abstract][Full Text] [Related]
17. GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform Architecture.
Jeyapala R; Savio AJ; Olkhov-Mitsel E; Kamdar S; Zhao F; Cuizon C; Liu RSC; Zlotta A; Fleshner N; van der Kwast T; Bapat B
Eur Urol Oncol; 2019 May; 2(3):231-238. PubMed ID: 31200836
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy.
Koie T; Mitsuzuka K; Yoneyama T; Narita S; Kawamura S; Kaiho Y; Tsuchiya N; Tochigi T; Habuchi T; Arai Y; Ohyama C; Yoneyama T; Tobisawa Y
Int J Clin Oncol; 2015 Feb; 20(1):176-81. PubMed ID: 24771079
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy.
Geybels MS; Wright JL; Bibikova M; Klotzle B; Fan JB; Zhao S; Feng Z; Ostrander EA; Lin DW; Nelson PS; Stanford JL
Clin Epigenetics; 2016; 8():97. PubMed ID: 27651837
[TBL] [Abstract][Full Text] [Related]
20. Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.
Graefen M; Noldus J; Pichlmeier U; Haese A; Hammerer P; Fernandez S; Conrad S; Henke R; Huland E; Huland H
Eur Urol; 1999; 36(1):21-30. PubMed ID: 10364651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
